S. YAPALI Et Al. , "Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study," AASLD TASL Digital Hepatology Meeting , vol.3, Turkey, pp.4, 2022
YAPALI, S. Et Al. 2022. Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study. AASLD TASL Digital Hepatology Meeting , (Turkey), 4.
YAPALI, S., GÖKCAN, H., harputluoğlu, M., MELEKOĞLU ELLİK, Z., GÖKÇEN, P., ADANIR, H., ... ARI, D.(2022). Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study . AASLD TASL Digital Hepatology Meeting (pp.4). , Turkey
YAPALI, SUNA Et Al. "Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study," AASLD TASL Digital Hepatology Meeting, Turkey, 2022
YAPALI, SUNA Et Al. "Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study." AASLD TASL Digital Hepatology Meeting , Turkey, pp.4, 2022
YAPALI, S. Et Al. (2022) . "Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study." AASLD TASL Digital Hepatology Meeting , Turkey, p.4.
@conferencepaper{conferencepaper, author={SUNA YAPALI Et Al. }, title={Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study}, congress name={AASLD TASL Digital Hepatology Meeting}, city={}, country={Turkey}, year={2022}, pages={4} }